Researchers have conducted the largest-ever retrospective cohort study for Japanese patients with glioblastoma (GBM), proposing an underlying prognosis biomarker responsible for the survival difference between two cohorts: an original Japanese cohort and a dataset from The Cancer Genome Atlas (TCGA).
from Latest Science News -- ScienceDaily https://ift.tt/2MmUYyp
No comments:
Post a Comment